Skip to main content
. 2021 Jan 23;2021:6688138. doi: 10.1155/2021/6688138

Figure 2.

Figure 2

Comparative survival outcomes according to pretreatment SIRI groups (red line: SIRI < 1.9 and dark blue line: SIRI ≥ 1.9): (a) progression-free survival; (b) overall survival.